Runben Biotechnology Co., Ltd. (SHA:603193)

Runben Biotechnology Revenue

Runben Biotechnology had revenue of 267.09M CNY in the quarter ending March 31, 2026, with 11.27% growth. This brings the company's revenue in the last twelve months to 1.57B, up 12.96% year-over-year. In the year 2025, Runben Biotechnology had annual revenue of 1.54B with 17.19% growth.

• Revenue (ttm): 1.57B
• Revenue Growth: +12.96%
• P/S Ratio: 6.85
• Revenue / Employee: 1.71M
• Employees: 921
• Market Cap: 10.77B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.54B	226.62M	17.19%
Dec 31, 2024	1.32B	285.22M	27.61%
Dec 31, 2023	1.03B	176.87M	20.66%
Dec 31, 2022	856.09M	273.94M	47.06%
Dec 31, 2021	582.15M	139.32M	31.46%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 4, 2026

Data Sources Report a data error